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doi:10.1016/j.ejvs.2009.09.024Abstract Objectives: Calcified plaques are suggested to represent atherosclerotic lesions
with stabilising properties. However, patients with chronic kidney disease (CKD) frequently
have calcified plaques but significant higher prevalence of cardiovascular complications. The
aim of our study was therefore to analyse the effect of CKD in patients with advanced carotid
stenosis (>70%) on plaque composition, lesion stability and risk of rupture.
Methods: We investigated retrospectively, by histology, carotid plaques of patients with high-
grade internal carotid artery stenosis undergoing carotid endarterectomy. Comparison of pla-
que morphology was performed on 41 patients with CKD with estimated glomerular filtration
rate (eGFR) < 60 ml min1 (according to the Modification of Diet in Renal Disease formula,
MDRD-eGFR) and 56 patients with normal renal function.
Results: Patients with CKD had significantly higher percentage of total calcification (17% vs.
7%, p< 0.001), unstable and ruptured plaques (83% vs. 52%, pZ 0.001 and 59% vs. 36%,
pZ 0.039, respectively) compared with patients with normal renal function. By contrast,
the content of collagenous fibres was significantly reduced in CKD patients (40% vs. 57%,
pZ 0.011). No significant differences were found for neurological symptoms and soft plaque
content.
Conclusion: Our results demonstrate that CKD significantly affects plaque composition in
patients with advanced carotid artery stenosis. Enhanced calcification and reduced collage-
nous plaque may lead to plaque instability and rupture.
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Patients with chronic kidney disease (CKD) have an up to
20-fold higher prevalence of premature arterial plaque
formation and cardiovascular complications compared with
the general population.1e4 Furthermore, atherosclerotic
plaques of CKD patients are often calcified with markedly
increased artery stiffness.2,4e7 The role of calcification in
atherosclerotic lesions and its contribution to plaque
vulnerability is, however, still controversial. Some studies
demonstrated the stabilising effects of calcium deposits in
atherosclerotic lesions by making the vessels stiffer and less
prone to rupture,8e10 whereas others observed a rather
destabilising effect and an increase of the risk of plaque
disruption.11e13 Nevertheless, coronary artery calcification
and calcium score were suggested as an independent
predictor of future cardiac events.14,15
To date, most studies were performed in coronary
arteries and the calcification was compared mainly
between CKD patients and healthy controls. Thus, only
little knowledge exists concerning plaque composition of
the cerebrovascular region in patients with CKD. Therefore,
the aim of our study was to investigate carotid plaque
morphology such as extent of calcification, collagenous and
soft plaque content, plaque stability and rupture in
patients with advanced carotid artery stenosis (>70%) with
and without renal insufficiency.
Materials and Methods
Study patients
In this retrospective study, we analysed in total 156 patients
with advanced carotid artery stenosis (>70%)with or without
CKD, who underwent carotid thrombo-endarterectomy
(CEA). Patients with neurological symptoms (transient
ischaemic attacks or non-disabling stroke) have been
assigned from the Institute of Neurology of the hospital
Klinikum rechts der Isar, Munich. The patients received an
intensive work-up with magnetic resonance imaging (MRI),
computed tomography (CT), Doppler and duplex ultrasound
of the brain vessels and cerebrovascular angiography. The
extent of stenosis was determined by measuring the peak
systolic velocity (PSV) by ultrasonography. Furthermore, all
patients were examined pre- and postoperatively by an
experienced neurologist. Surgical intervention was
performed in accordance with the clinical practice guidance
for CEA to avoid stroke occurrence. Patients without neuro-
logical symptoms have been diagnosed within the scope of
a clinical work-up in consequence of arterial hypertension
and/or diabetes mellitus type 2 or by random screenings.
They were assigned to the Vascular Centre of the Technical
University Munich by their family practitioner or specialist in
internal medicine or angiology. Furthermore, patients were
postoperatively attended by the consultant of the Internal
Medicine Department and those with CKD by the nephrolo-
gist. The study criteria for patient sampling was estimated
glomerular filtration rate (MDRD-eGFR, according to the
formula developed by the Modification of Diet in Renal
Disease, cut-off point< 60 ml min1 16), availability of
histological specimens and detailed clinical parameters.Patients with dialysis (eGFR< 15 ml min1), autoimmune
disease and ongoing steroid or other immunosuppressive
medicationwereexcluded from the study. Thus, 107patients
with carotid artery stenosis>70%werefinally included in this
retrospective study, with 41 patients with and 56 patients
without CKD.
Histological and blood sample analysis
Following CEA, carotid plaques were fixed with formalin,
segmented to pieces of 3e4 mm and embedded in paraffin.
Each segment was cut in slides of 2e3 mm, stained by
haematoxylin/eosin or van Gieson’s picro-fuchsin and digi-
talised. Calcified, soft and collagenous areas were labelled
and monitored as a percentage of whole plaque area
without lumen by two independent and experienced
experts blinded for the study groups. Finally, for the clin-
ical relevance and comparison between the groups, the
most advanced atherosclerotic areas were used. All plaques
were classified according to Stary’s classification.17 This
classification describes plaque composition in eight types
from moderate and stable atherosclerotic lesions (IeIV) to
unstable and complicated (VeVII) and VIII as advanced
fibrous lesion. Our patients displayed all the type VeVII (VII
describes calcified lesions) plaques. For the determination
of plaque stability, modified AHA characterisation accord-
ing to Virmani and Burke was applied,18 where plaques with
thin cap fibro-atheroma over large necrotic core (charac-
terised by a massive aggregate of extracellular lipid,
necrotic cells, thrombosis, haemorrhages and few collage-
nous fibres17,18) were classified as unstable. Plaques were
graded as ruptured when they contained intra-plaque
thrombus and incomplete cap layer. Furthermore, collag-
enous and soft plaques were determined. Atherosclerotic
lesions with lipid-rich necrotic atheromatous area and few
collagen fibres were classified as soft plaque. By contrast,
collagenous plaques were rich on collagenous fibres and
were far more stable compared with soft plaques.
Blood samples were taken from all patients within 2 days
prior to surgical intervention, centrifuged at 1000 g for
10 min at 4 C and store at 70 C until analysis. Clinical
serum parameters such as urea nitrogen, creatinine, crea-
tine kinase and other blood sample parameters were
measured according to the standardised protocols in the
Department of Clinical Chemistry (Klinikum rechts der Isar,
Technische Universitaet Muenchen).
Statistical analysis
All statistical analyses were performed by using SPSS 17.0
for Windows (SPSS Inc., Chicago, IL, USA). Differences
between groups are shown as a mean standard deviation
(SD) for continuous variables or as a percentage for cate-
gorical variables. One-sample KolmogoroveSmirnov test
was performed to prove samples for normal distribution.
For normal distributed samples, the t-test was applied;
samples without normal distribution were analysed by the
ManneWhitney approach. For the nominal variable gender
and neurological symptoms, Fisher’s exact test was
applied. Subgroup analysis was performed by using non-
parametric KruskaleWallis one-way test of variance.






Age [years]a 73.5 6.9 72.3 6.1 0.346
Gender [% males]c 78.0 57.1 0.050
BMI [kg/m2]a 26.3 4.1 25.5 3.6 0.102
Neurological symptomsd [%]c 43.9 44.6 0.942
Degree of stenosis [% of lumen]b 82.5 (70e95) 80.0 (70e95) 0.570
Anaemiae [%]c 29.3 10.7 0.033
Hypertension [%]c 92.3 76.0 0.102
Hyperlipidemia [%]c 72.2 67.9 0.815
Diabetes [%]c 33.3 30.2 0.818
Blood urea
nitrogen [mg/dL]a
26.4 9.1 15.9 4.6 <0.001
Creatinine [mg/dl]a 1.5 0.4 0.8 0.1 <0.001
eGFR [mL/min]a 49.8 10.1 86.6 14.8 <0.001
53.2 (20.6e59.5)f 87.5 (62.2e140.7)f
ASS [%]c 86.1 94.2 0.264
Statins [%]c 61.1 69.2 0.496
a Normal distributions, independent two sample t-test (mean SD).
b Mann-and-Whitney U-test, displayed as mean (range).
c Nominal variables, Fisher’s exact test. ASS: acetylic salicylic acid (100 mg/day).
d Neurological symptoms were defined according to the European Carotid Surgery Trial (ECST): the patients had experienced in the
previous 6 months one or more carotid-territory ischaemic events in the brain or eye, which were either transient (symptoms lasting
minutes, hours, or days) or permanent but did not cause any serious disability.
e Hb< 12.0 g/dL for women, <13.0 g/dL for men.
f Median (range).
Carotid Plaque Composition and Renal Insufficiency 13Correlations between continuous variables were quantified
by using Spearman’s rank correlation coefficient.Results
Demographic data of the study patients (nZ 107) are
summarised in Table 1. No differences were observed
between the groups (nZ 41 for patients with CKD, nZ 56
for patients without CKD) regarding age, body mass index
(BMI) or associated diseases. Haemoglobin concentration
was decreased and blood urea nitrogen was higher in indi-
viduals with CKD corresponding with the impaired renal
function. In the CKD group, 43.9% of the patients had
preoperative neurological symptoms and 44.6% of the






Calcification [%]a 17 (2e66) 7 (0e39) <0.001
Collagenous
plaque [%]a
40 (5e88) 57 (8e94) 0.011







a Mann-and-Whitney U-test, displayed as mean (range).
b Nominal variables, Fisher’s exact test.transient ischaemic attacks or non-disabling stroke. The
occurrence of neurological symptoms postoperatively
was 2.8%.
Patients with renal insufficiency exhibited significantly
higher percentage of calcification compared with patients
without CKD (21.2 16.1 vs. 10.9 9.8, p< 0.001)
(Table 2). The group of CKD patients had also significantly
more unstable and ruptured carotid plaques (81.9% vs.
51.8%, pZ 0.001 and 58.5% vs. 35.7%, pZ 0.039, respec-
tively). Whereas soft plaque formation was similar between
the groups, collagenous plaque formation was significantly
reduced in patients with CKD (40.4 19.5% vs.
53.5 21.8%, pZ 0.011). In addition, no significant differ-
ences between both groups were found regarding neuro-
logical symptoms (Table 1). Representative examples of
different plaque morphology of two patients with high-
grade carotid artery stenosis with and without CKD are
shown in Fig. 1.
To compare the severity of CKD with the plaque
morphology, a subgroup analysis was performed, with
a separate analysis of four patients’ subgroups depending
on their eGFR values; 1: 15e29 mlmin1, 2:30e
59 ml min1, 3: 60e90 mlmin1, 4: >90 ml min1. Then
again, plaque stability, rupture and calcification demon-
strated significant differences between all subgroups cor-
responding with the severity of CKD (pZ 0.006, pZ 0.047,
and pZ 0.003, respectively). An example of the subgroup
analysis for calcification is shown in Fig. 2.
Furthermore, correlations coefficients were calculated
for eGFR values, as were the degree of calcification and
collagenous content. Negative correlation was found
between eGFR concentration and calcification (rZ0.367,
Figure 1 Representative example of different plaque morphology of two patients with advanced carotid artery stenosis with
(a; 67 years, eGFRZ 23.9 mL/min) and without (b; 69 years, eGFRZ 102.1 mL/min) renal insufficiency. Elastica van Gieson
staining was performed to show collagenous fibres. Arrows show calcified areas.
14 J. Pelisek et al.pZ 0.001) and positive correlation between eGFR and
collagenous plaque content (rZþ0.286, pZ 0.008).
Discussion
The results of our present study show that the composition
of atherosclerotic lesions in patients with CKD is altered in
carotid arteries as compared with patients with normal
renal function. So far, it has not yet been analysed whether
plaque morphology might change due to the impaired renal
function, especially in the cerebrovascular vessels.
Furthermore, in the most studies, calcification was ana-
lysed mainly by ultrasonography.5,19,20 This method,
however, does not allow for reliable quantification of
calcification, especially within the intima, because of the
insufficient image resolution. In our present study, we
performed detailed morphological analysis of carotid pla-
ques in patients undergoing CEA that comprises only theFigure 2 Subgroup analysis of calcification depending on
severity of CKD. Patients were divided according to eGFR
values as follows: 1, 15e29 mL/min; 2, 30e59 mL/min; 3,
60e90 mL/min; 4, >90 mL/min.intimal part of the carotid artery. In addition, we have
involved only those patients with advanced carotid artery
stenosis >70% and compared them with individuals with
CKD. The number of symptomatic patients was about 44% in
both groups. The diagnostic and surgical procedure of our
study is based on the results of former randomised
controlled trials (Asymptomatic Carotid Atherosclerosis
Study, ACAS; and Asymptomatic Carotid Surgery Trial,
ACST) that concluded that CEA reduces the risk of stroke
also in asymptomatic patients younger than 75 years of age
with carotid diameter reduction of >70%. Diagnostics of
carotid artery stenosis is performed in neurological
asymptomatic patients by screening in the context of other
diseases such as peripheral arterial occlusive disease,
aortic aneurysm, severe hypertension or, for example, eye
examination.21e25 Neurological symptomatic patients were
referred for CEA mainly by the neurologist. These circum-
stances explain the fact that the majority of carotid artery
patients in our study were asymptomatic.
Remarkably, although the calcium deposits and plaque
instability correlated significantly with the severity of CKD,
no significant differences were observed for the incidence
of neurological symptoms. The reason for this discrepancy
might be the heterogeneity of our study population, the
retrospective nature of the study, and the limited number
of the study patients. Interestingly, while in the group of
asymptomatic patients, both plaque instability and rupture
significant correlated with the severity of CKD (rZþ0.457,
p< 0.001 and rZþ0.353, pZ 0.007, respectively), no
significant relationship was found for symptomatic
patients. Furthermore, the neurological symptoms do not
necessarily originate from ruptured carotid lesions.26 Only
20e30% of ischaemic strokes are caused by carotid artery
disease. Our results confirm our presumption that not
symptoms but plaque instability is more accurate for
assessing clinical outcome and associated disease.
Based on histological and serological investigations, the
present study confirms a higher degree of calcification in
patients with impaired renal function. However, in contrast
to the studies where ultrasound was used for detection of
calcified regions,5,7,19 in our histological studies, the average
Carotid Plaque Composition and Renal Insufficiency 15proportion of calcification was, at 17%, relatively low. The
variation in patients with CKD with up to 66% was however
quite broad. The reason for this discrepancy with regard to
ultrasonographic studies is that we determined calcium
deposits in the intima part of the carotid artery by CEA. By
contrast, sonography measures calcification of the entire
carotid vessel wall. However, the intimal changes within the
carotid artery are of clinical relevance, indicating stroke or
TIA by, for example, plaque rupture. Whether extended
calcification and impaired renal function are related to the
plaque instability is still unclear.4,9 In our study, the carotid
plaques of patients with impaired renal function also had
significantly reduced content of collagen fibres. CKD
frequently leads to a disturbed calcium balance in the blood
and enhanced accumulation of calcium within atheroscle-
rotic plaques. Calcium phosphate promotes the death of
vascular smooth muscle cells and consequently impairs the
synthesis of collagen. Our results assume a possible influence
of calcification (of CKD patients) on plaque composition that
may lead to enhanced plaque instability and a cerebrovas-
cular event. Thus, irrespective of enhanced calcification,
impaired renal functionmay also cause additional changes in
plaque composition, such as the decrease of smooth muscle
cells that would explain the observed reduction of collage-
nous fibres within the plaques of CKD patients.27
For the interpretation of our results, different limita-
tions have to be taken into account. First, independent of
the careful characterisation of all segments of the carotid
plaques of study patients, in some cases unremarkable
rupture could still escape our attention. However, due to
the exclusion of patients without well-defined plaques
morphology and the consultation of our histological findings
with an experienced pathologist, these mistakes were
reduced to a minimum. Second, our data are of a retro-
spective nature; thus we were not able to achieve all
desirable data for all study patients. Third, in some cases,
the histological findings were quite heterogeneous and the
results showed broad variation; consequently, 107 carotid
artery patients with 41 CKD individuals are still a relatively
small group to draw accurate conclusions. Thus, further
prospective studies are necessary to confirm the results of
our present study.
In summary, our histological study demonstrates signifi-
cant increase of calcium deposits within the intimal part of
atherosclerotic plaques in patients with CKD and advanced
carotid artery stenosis. Furthermore, additional changes in
plaque composition such as significant reduction of the
content of collagenous fibres were observed. Further
prospective case control studies are necessary to evaluate
the role of increased plaque instability caused by calcifi-
cation and reduced collagenous fibre content for the clin-
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